
Exim Routes IPO Subscription Day 1
Posted by : sachet | Fri Dec 12 2025

Here, the Exim Routes IPO launched on 12th December 2025. Bidding for the issue will close today, 19th December 2025. The primary aim of the Exim Routes IPO is to raise ₹43.73 crores from the market. Also, the Exim Routes IPO has received an impressive level of subscription, indicating that the shares will be listed at an impeccable premium. Scroll down to check the Exim Routes IPO subscription and details.
Exim Routes IPO Details
| IPO Open Date | 12th December 2025 |
| Face Value | ₹5 per share |
| Price Band | ₹83 to ₹88 per share |
| Lot Size | 1,600 Shares |
| Issue Type | Bookbuilding Issue |
| Listing At | NSE & SME |
| IPO Close Date | 16th December 2025 |
| Listing Date | 19th December 2025 |
The price band for Riddhi Display Equipment’s IPO has been set at ₹83 to ₹88 per share, and a total of 49,69,600 shares are being issued. Let’s segregate the share quota fixed for different categories of investors.
| Categories | Shares Offered | Shares Percentage |
| Market Maker Shares Offered | 2,49,600 | 5.02% |
| QIB shares offered | 23,52,000 | 47.33% |
| NII (HNI) Shares Offered | 7,10,400 | 14.29% |
| Retail Shares Offered | 16,57,600 | 33.35% |
| Total Shares Offered | 49,69,600 | 100.00% |
Exim Routes IPO Subscription Status
As of now, the Exim Routes IPO has been subscribed to 0.10 times. Of these, 0.13 times are subscribed by retail investors, 0.17 times by non-institutional investors, and 0.00 times by QII (Qualified Institutional Investors).
The healthy subscription status indicates that investors are expecting higher returns at the time of Exim Routes’s IPO listing on 19th December 2025. Exim Routes also has a positive outlook behind the fresh issue of 0.50 crore shares, which will raise around Rs 43.73 crores.
Exim Routes IPO GMP Today

We know that higher subscription levels drive grey-market premiums for IPOs. Let’s explore the Exim Routes IPO GMP for 12th December 2025.
The grey market premium for this IPO has surged to 10.23% or Rs 9.00 per share. It indicates that the estimated listing price per share is Rs 97.00. Numerous factors played a pivotal role in this jump in the GMP of Riddhi Display Equipment’s IPO. These include higher subscription rates, favourable market sentiment, and investors’ positive attitude towards IPOs.
| GMP DATE | IPO Price | GMP Price | Estimated Listing Price | Estimated Gain |
| 12-12-2025 | ₹88.00 | ₹9.00 | ₹97.00 | 10.23% |
| 11-12-2025 | ₹88.00 | ₹9.00 | ₹97.00 | 10.23% |
| 10-12-2025 | ₹88.00 | ₹6.00 | ₹94.00 | 6.82% |
| 9-12-2025 | ₹88.00 | ₹6.00 | ₹94.00 | 6.82% |
| 8-12-2025 | ₹88.00 | ₹6.00 | ₹94.00 | 6.82% |
About Exim Routes Ltd.
Exim Routes was established in April 2019. Exim Routes Limited is a global platform that facilitates the exchange of recyclable paper materials, offering end-to-end services to Indian Paper Mills, from sourcing waste paper to quality assurance and logistics. The Company operates through a group structure, with an Indian parent, Exim Routes Limited, and foreign subsidiaries. Exim Routes is a global recyclable exchange company focused on facilitating cross-border trade in recyclable materials, particularly paper and metal scrap. Exim Routes uses its proprietary AI-powered B2B platform (referred to as “ERIS”) to connect buyers and sellers of recyclable paper, streamlining procurement, supply-chain and delivery.
Exim Routes Limited Financials
The company’s financial analysis is essential before applying for the Exim Routes IPO. Look at the table to learn about Exim Routes Limited’s financials.
| Year Ended | 30th June 2025 (in cr.) | 31st March 2025 (in cr.) | 31st March 2024 | 31st March 2023 |
| Assets | 50.97 | 47.62 | 20.53 | 6.63 |
| Revenue | 44.17 | 120.99 | 72.39 | 36.46 |
| Profit After Tax | 1.17 | 7.56 | 4.20 | 0.37 |
| EBITDA | 1.39 | 9.95 | 4.58 | 0.64 |
| Net Worth | 16.38 | 15.60 | 1.18 | 0.56 |
| Reserves and Surplus | 15.71 | 14.41 | 3.58 | 0.53 |
| Total Borrowings | 5.10 | 2.75 | 1.46 | 2.86 |
Explanation
Exim Routes Limited’s revenue increased by 67% from ₹72.39 crores in March 2024 to ₹120.99 crores in March 2025. Moreover, the company’s PAT increased by 80% from ₹4.20 crores in March 2024 to ₹7.56 crores in March 2025.
Technical Indicators
Several technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technical aspects of the Exim Routes IPO.
| Key Indicators | Value |
| PE Ratio (Price-to-Earnings) | 16.04 |
| EPS (Earnings Per Share) | 5.49 |
| RoNW | 42.28% |
| ROCE | 26.81% |
| ROE | 42.28% |
| EBITDA Margin | 8.24% |
| Price to Book Value | 7.77 |
| Market Capitalisation | ₹165.02 Cr |
Exim Routes IPO Listing Expectations
Exim Routes IPO Highlights: IPO allotment is still pending, as the bid will close today. However, given the current GMP or market sentiment, it is reasonable to expect higher listing gains for the share. A jump of 10.23% in Yash Highlight GMP suggests the estimated listing price per share will be around Rs 97.
It will provide higher listing gains to investors who applied for this IPO. Also, the financial fundamentals of this business made it the experts’ top long-term recommendation.
Exim Routes IPO Dates
| IPO Open Date | 12th December 2025 |
| IPO Close Date | 16th December 2025 |
| Allotment | 17th December 2025 |
| Refund Date | 18th December 2025 |
| IPO Listing Date | 19th December 2025 |
Note: IPO GMP is volatile and depends on market sentiment. Hence, one should conduct their research before investing in it.
Recent Articles
Icodex Publishing Solutions IPO GMP: Day 1 IPO Live Updates
Bluestone Jewellery IPO GMP: Day 1 IPO Live Updates
Highway Infrastructure IPO Listing Preview: What to Expect Now in 2025?
Concord Biotech Q1 Results FY26: Q1 PAT Falls 26.07% to ₹44.06 Crore; Revenue Down 5.47% YoY
Sawaliya Foods Products IPO Allotment Status Check Online: GMP, Subscription, Price, and More
Exim Routes IPO Allotment Status Check Online: GMP, Subscription, Price, and More
Mahendra Realtors IPO GMP & Review: Apply or Avoid?
Regaal Resources IPO GMP & Review: Apply or Avoid?
Icodex Publishing Solutions IPO GMP & Review: Apply or Avoid?

